LionGate

Long Position ADAP - Reaching All time low (BE CAUTIOUS)

Long
LionGate Updated   
NASDAQ:ADAP   Adaptimmune Therapeutics plc
As the company ADAP has not been performing as desired within the last few years, an analysis may manifest that the trajectory for the stock valuation has almost amassed an all-time low valuation.

Not investment advice. For personal and educational purposes only. (Move with caution and due diligence)
Trade closed: target reached:
Take Profit, as the stock valuation has breached through prior resistance!

- LionGate
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.